Supernus Pharmaceuticals, Inc. is a specialty pharmaceuticals company focused on developing specialty products using its patented and proven technologies and product development capabilities. Supernus is developing several product candidates in neurology and psychiatry to address unmet medical needs and opportunities in epilepsy, attention-deficit hyperactivity disorder (ADHD) and its coexisting disorders, and depression.

Acquired Companies: Shire Laboratories